Oncotarget, Author at Oncotarget

Panitumumab and Low-Dose Capecitabine: A Promising Maintenance Therapy for Metastatic Colorectal Cancer

Considerations around maintenance therapy are of particular importance when drugs associated with cumulative neurotoxicity like... read more

May 7, 2025

studies that employ TP53-wild type cancer cells and their isogenic derivatives may systematically fail to... read more

April 22, 2025

Osteosarcoma is characterized by a complex genetic profile that leads to significant genetic instability, which... read more

April 9, 2025

Donor cell-derived hematologic neoplasms are extremely rare complications that arise after hematopoietic stem cell transplantation."... read more

March 26, 2025

This case adds to the literature on bypass signaling as a mechanism of resistance to... read more

March 12, 2025

The concentration of cell-free DNA (cfDNA) before and after surgery may be related to the... read more

February 26, 2025

HER2-low breast cancer is unlikely to represent a unique biologic or clinical subtype but rather... read more

February 12, 2025

The anti-correlation of PD-1 and KLRG1 expression in human tumor infiltrating CD8 T cells suggests... read more

January 28, 2025

To our knowledge, this is the first case/control study to show a significant genetic... read more

January 15, 2025

While the test poses minimal physical risk, there is no assurance of “safety” from psychological... read more

January 3, 2025